Tocilizumab is associated with reduced delirium and coma in critically ill patients with COVID-19 von Alkhateeb, Tuqa, Stollings, Joanna L., Sohn, Ine, Liu, Dandan, Fleenor, L. Montana, Ely, E. Wesley, Lahiri, Shouri

Volltext

958: INCIDENCE OF ADVERSE EFFECTS DURING PERIPHERAL VASOPRESSIN ADMINISTRATION von Fleenor, Montana, Patel, Sneha, Dillon, Ryan

Volltext

1290: PHENOBARBITAL VERSUS BENZODIAZEPINE-BASED REGIMEN FOR ALCOHOL WITHDRAWAL SYNDROME IN TRAUMA PATIENTS von Fleenor, Montana, Beavers, Jennifer, Tidwell, William, Atchison, Leanne, Medvecz, Andrew, Beyene, Robel, Kast, Kristopher, Marcovitz, David, Dennis, Bradley, Guillamondegui, Oscar, Smith, Michael

Volltext

Validation and evaluation of a prior‐to‐admission medication list discrepancy risk‐scoring tool von Fleenor, L. Montana, McCluggage, Lauren K., Schell, Ryan F., VanCleave, Halden Z., Nelson, Scott D.

Volltext

Pharmacist administered parenteral medications: A descriptive report of an inpatient training program von Dillon, Ryan C., Leffler, Carmen, Schell, Ryan F., Sherlin, Kristen C., Fleenor, L. Montana, McLaughlin, Linda B.

Volltext